These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1827005)

  • 1. Isradipine in the treatment of hypertension. Some additional effects observed during a one-year study.
    Mayer O; Polivkova H; Rottenborn J
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):140S-143S. PubMed ID: 1827005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihypertensive effect of isradipine on blood pressure at rest and during exercise.
    Dvorák I; Blaha M; Nĕmcová H
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):144S-146S. PubMed ID: 1673616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved blood pressure control with isradipine in hypertensive patients treated with pindolol.
    Frithz G; Aström B; Dahlöf B; Hansson L; Tollin C; Himanen P; Sundstedt CD
    Am J Med; 1989 Apr; 86(4A):115-8. PubMed ID: 2523645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of isradipine in hypertension.
    Shepherd AM; Carr AA; Davidov M; Hamilton J; Schnaper H; Velasquez M; Brockway B; Prisant LM; Hamilton B; Gonasun L
    J Cardiovasc Pharmacol; 1989 Apr; 13(4):580-5. PubMed ID: 2470995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time course of the blood pressure response to oral isradipine in uncomplicated mild-to-moderate essential hypertension.
    Leary WP; Reyes AJ; Maharaj B; van der Byl K
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):147S-150S. PubMed ID: 1827006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the new calcium entry blocker isradipine (PN 200-110) in essential hypertension.
    Staessen J; Lijnen P; Fagard R; Hespel P; Tan WP; Devos P; Amery A
    J Cardiovasc Pharmacol; 1989 Feb; 13(2):271-6. PubMed ID: 2468957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive activity of isradipine in humans: a new dihydropyridine calcium channel antagonist.
    Nelson EB; Pool JL; Taylor AA
    Clin Pharmacol Ther; 1986 Dec; 40(6):694-7. PubMed ID: 2946507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of isradipine on platelet function in hypertension at rest and during exercise.
    Fitscha P; Virgolini I; Rauscha F; Sinzinger H
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):178S-180S. PubMed ID: 1827015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of isradipine on 24-h blood pressure profile demonstrated by repeated monitoring.
    Cihák R; Widimský J; Lefflerová K; Janský P
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):158S-160S. PubMed ID: 1827009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihypertensive and renal effects of isradipine in essential hypertension: focus on renin system activity.
    Allikmets K; Parik T; Teesalu R
    Angiology; 1997 Nov; 48(11):977-83. PubMed ID: 9373050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter comparison of once- and twice-daily isradipine to hydrochlorothiazide for the treatment of hypertension in elderly patients.
    Holtzman JL; Abrams A; Cutler R; Hamilton B; Kirkendall WM; Neri G; Stein GH; Matthews KP
    Clin Pharmacol Ther; 1990 Nov; 48(5):590-7. PubMed ID: 2146060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Twenty-four-hour blood pressure control with isradipine in mild essential hypertension.
    Viskoper JR; Laszt A; Faraggi D
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):161S-162S. PubMed ID: 1827010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isradipine in monotherapy and in combination with bopindolol: results of a 3-month multicentre study in hypertensives.
    Dzúrik R; Fetkovská N; Dvorák I; Jonás P; Markuljak I; Petr P; Kotlík I; Widimský J
    Cor Vasa; 1990; 32(2 Suppl 1):42-53. PubMed ID: 1974488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isradipine twice daily lowers blood pressure over 24 H.
    Man in't Veld AJ; Holmes DG; Lasance A; de Zwart P
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):131S-134S. PubMed ID: 1827003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter evaluation of efficacy, tolerability and safety of a new first-line antihypertensive drug, isradipine, in a Latin-American population.
    Gómez G; Melgarejo E; Narváez J; Gamarra G; Restrepo G; Acevedo L; Izurieta A
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):128S-130S. PubMed ID: 1827002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicenter evaluation of the safety and efficacy of isradipine in hypertension. The Italian-Belgian Isradipine Study Group.
    Am J Med; 1989 Apr; 86(4A):94-7. PubMed ID: 2523664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive effects of isradipine and captopril as monotherapy or in combination.
    Fitscha P; Meisner W; Hitzenberger G
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):151S-153S. PubMed ID: 1827007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isradipine: overall clinical experience in hypertension in the United States.
    Miller H
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):135S-139S. PubMed ID: 1827004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood pressure control and haemodynamic adaptation with the dihydropyridine calcium antagonist isradipine: a controlled study in middle-aged hypertensive men.
    Andersson OK; Persson B; Hedner T; Aurell M; Wysocki M
    J Hypertens; 1989 Jun; 7(6):465-9. PubMed ID: 2528578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicentre isradipine dose-confirmation study in Thai patients with hypertension.
    Tanomsup S; Tantbirojn P; Koanantakul B; Nontakanun S; Jaroonvesama N; Charoenlarp K
    Drugs; 1990; 40 Suppl 2():22-5. PubMed ID: 2150635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.